Experienced senior executive and team leader with an extensive successful history of optimizing value and accelerating equity growth. Seasoned Chief Executive; Operating; and Investment Officer. Hands-on leadership skills at the operational level. Board of Director experience in dealing with co-investors, lenders, operational management teams, accountants, consultants and lawyers. Extensive experience in the lead role in negotiations in the context of realization events, re-capitalizations, subsequent equity raises, and management re-organizations. Skilled in financial analysis, strategy formulation and execution, and team building. Over 25 years of experience in negotiating with and effectively aligning the interests of all constituents of a high-growth, venture-backed business. Strong public speaking and presentation skills. MBA from INSEAD in Fontainebleau, France and BS in Applied Economics from Cornell University.
Keith Crandell will serve on our board of directors following this offering. Mr. Crandell is a co-founder and has served as a Managing Director of ARCH Venture Partners since July 1994, where he focuses on life science tools, devices, and diagnostics. He currently serves on the Board of Directors of Quanterix Corporation (Nasdaq: QTRX), a publicly-traded company focusing on ultra-sensitive digital biomarker detection; Twist Bioscience (Nasdaq: TWST), a publicly-traded synthetic biology company whose silicon-based DNA writing platform offers broad application across the life science and biotherapeutics, and 908 Devices Inc. (Nasdaq: MASS), a publicly-traded company focused on bringing mass spectrometry to bio discovery and processing and field forensic applications. Mr. Crandell has played a key role in the formation and initial funding round of life science companies, including Quanterix Corporation, Twist Bioscience; and 908 Devices Inc., among others. Mr. Crandell is also a director of several private companies and serves on the Entrepreneurship Advisory Board at the Polsky Center for Entrepreneurship and Innovation of the University of Chicago Booth School of Business, the University of Chicago Pritzker School of Molecular Engineering Advisory Council, and on the Investment Advisory Board for the Partners Innovation Fund, a venture capital fund affiliated with Harvard Medical School Hospitals. Mr. Crandell has a B.S. degree in chemistry and mathematics from St. Lawrence University, an M.S. in chemistry from the University of Texas at Arlington, and an M.B.A. from the University of Chicago.
Patrick is a Venture Partner at Madrona Venture Group. He has more than 25 years of experience as a scientist, engineer, businessman, and venture capitalist. Patrick was at Intellectual Ventures for more than 10 years, most recently running startup incubation and technology commercialization around the world. His investments included Evolv Technology (Nasdaq: EVLV) of which he was a founding board member. He was also the founding CTO of Xinova, an Intellectual Ventures spinout that pioneers an international open-innovation market network.
Previously Patrick was a Managing Director of ARCH Venture Partners where he funded and built early stage startups from universities and national labs in a variety of markets and technologies. His investments included Impinj (Nasdaq: PI), and Innovalight (acquired by DuPont).
Prior to joining the venture capital industry as a Kauffman Fellow, he held positions with Lucent Technologies, AT&T, and Bell Labs. Patrick led engineering projects for software development, speech recognition, network design and operations. He also worked in product management for the optical networking business and marketing where he led new product launches.
Before joining Bell Labs, Patrick conducted research in Nuclear Physics in North America and Europe. He published many articles in scientific journals including The Physical Review, Zeitschrift für Physik and Nuclear Instruments and Methods.
Patrick has served on the boards of 21 venture backed companies, in addition to several non-profit boards. His current memberships include: Wipro Ltd, the Cybereason Advisory Board and the University of Helsinki Commercialization Board. He is a Senior Fellow at the Potomac Institute. He is an inventor on several patents, has written about innovation and is a frequent speaker at conferences.
In the last decade, Patrick has spent more than 1,000 days abroad conducting business in 31 countries and developing relationships with leaders in the technology, corporate and academic worlds.
His degrees include: a PhD, MS, and MPhil in Physics from Yale, an MBA from Wharton, and a BS in Mathematics and Physics from the College of William and Mary where he was elected to Phi Beta Kappa.